Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jean-Jacques Bienaime
Pharma
Activist investor Elliott takes $1B stake in BioMarin: report
Newly profitable BioMarin has garnered the attention of activist investor Elliott Management, Reuters reported Tuesday.
Fraiser Kansteiner
Nov 8, 2023 8:25am
Genentech's Alexander Hardy steps down, will become BioMarin CEO
Nov 1, 2023 7:21pm
BioMarin on its way to turning a profit in 2022
Apr 28, 2022 9:50am
BioMarin gears up for two 'transformational' launches: CEO
Aug 2, 2021 11:05am
BioMarin's long-time CEO Bienaime collects $18M package in 2020
May 4, 2021 12:08pm
BioMarin's gene therapy might bleed off the hem A market
Jan 14, 2020 9:35am
